Can Halberg’s chronotherapy approach increase efficacy and safety of PCSK9 inhibitors and decrease their adverse effects?

Ram B. Singh, Germaine G Cornelissen-Guillaume, Anna Gvozdjáková, Jan Fedacko, Banshi Saboo, Anuj Maheshwari

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationCurrent Trends in Cardiovascular Research
PublisherNova Science Publishers, Inc.
Pages203-206
Number of pages4
ISBN (Electronic)9781634856744
ISBN (Print)9781634856461
StatePublished - Jan 1 2016

Cite this

Singh, R. B., Cornelissen-Guillaume, G. G., Gvozdjáková, A., Fedacko, J., Saboo, B., & Maheshwari, A. (2016). Can Halberg’s chronotherapy approach increase efficacy and safety of PCSK9 inhibitors and decrease their adverse effects? In Current Trends in Cardiovascular Research (pp. 203-206). Nova Science Publishers, Inc..